MYD88 and hepatocellular carcinoma: Recent studies have shown that the TLR4/MyD88 pathway regulates NF-κB signaling and VEGF, IL-23, and IL-17A expression in HCC (Kang et al., 2018; Ding et al., 2019; Zhang et al., 2020).